In summary, our findings reveal an unanticipated ability of FASN-catalyzed endogenous lipogenesis to modulate the sensitivity of breast cancer cells to E2-dependent ERα signaling via regulation of non-genomic MAPK/ERα and AKT/ERα cross-talk. The gene discussed is FASN; the disease is breast cancer.